Mucotect Sustained Release Tablet 150 mg (Rabamipid)

Adult dose

Adults should take 1 tablet twice a day, one in the morning and one in the evening. This medication should be swallowed whole and should not be divided or chewed.

This medication should not be administered to patients with hypersensitivity to its ingredients. Additionally, this medication contains lactose and should not be used by patients with genetic conditions such as galactose intolerance, Lapp lactase deficiency, or glucose-galactose malabsorption. Attention is needed as various adverse reactions including gastrointestinal symptoms, infections, and musculoskeletal pain may occur when taking this medication. Particularly mild symptoms such as headache, dizziness, nausea, and diarrhea may appear, and while serious adverse reactions occur rarely, if symptoms arise, immediate consultation with medical personnel is advised. Women who are pregnant or may become pregnant should exercise caution as the safety of this medication has not been established, and it is recommended that breastfeeding be avoided. The safety of this medication in children and adolescents has not been sufficiently confirmed, hence caution is required for use. Elderly patients may have diminished bodily functions, thus should be more cautious regarding gastrointestinal symptoms and other adverse reactions. This medication must be kept out of reach of children, and transferring it to another container may compromise its quality, which should be avoided.

Serious side effects

Hives, severe swelling (edema), severe allergic reactions (symptoms of shock, anaphylaxis), leukopenia, thrombocytopenia, liver dysfunction, jaundice, severe skin adverse reactions (rash, blisters, skin peeling, mucosal pain in mouth/eyes), severe neurological symptoms (paralysis), respiratory issues (shortness of breath, cough, respiratory difficulty), severe swelling or urination abnormalities (generalized severe edema)

Mild side effects

Gastrointestinal disturbances (nausea, abdominal distension, constipation, diarrhea, dyspepsia), infections and parasitic (nasopharyngitis, epididymitis, pharyngotonsillitis), musculoskeletal and connective tissue disorders (myalgia, arthralgia), neurological disorders (dizziness, headache), skin and subcutaneous tissue disorders (dry skin, eczema, pruritus), mental disorders (depression, insomnia), respiratory system abnormalities (cough, oropharyngeal pain), hematological abnormalities (leukopenia), cardiac disorders (palpitations)

This medication may be sensitive to air or moisture, thus should be stored in a tightly sealed container. Additionally, it is important to store it at a temperature between 1 degree and 30 degrees Celsius for safe storage.

Appearance

White round sustained release tablet

Package unit

30 tablets/bottle, 300 tablets/bottle